Davis Polk Advises China Cinda on a Strategic Investment by Sino Biopharmaceutical
Davis Polk is advising China Cinda Asset Management Co., Ltd. (“China Cinda”) in connection with a proposed strategic investment by Sino Biopharmaceutical Limited. Pursuant to terms of the…